Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atezolizumab vs Chemotherapy in Platinum-Treated Advanced Urothelial Carcinoma
NCT02302807Phase 3Completed
- Sponsor
- Roche
- Start
- Jan 2015
- Primary completion
- Mar 2017
- Modality
- Monoclonal Antibodies
- Countries
- 29
01
Overview
A Phase 3 trial of atezolizumab in Urothelial Bladder Cancer (UBC), sponsored by Roche. Started Jan 2015; status: completed.
02
Drugs
atezolizumab
03
Conditions
Urothelial Bladder Cancer (UBC)
Beyond the preview
Go deeper on NCT02302807.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02302807.